Lina Wu

Lina Wu

Auto-generated profile, based on publicly available information

Lina Wu

Department of Laboratory Medicine, ShengJing Hospital of China Medical University, Shenyang, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 May 2024 in Critical Reviews in Clinical Laboratory Sciences
Verified
Journal Article
Closed access
YGYi Gao
Yi Gao
TDTianming Du
Tianming Du
LYLianbo Yang
Lianbo Yang
LWLina Wu
Lina Wu
This article comprehensively elucidates the discovery of Krebs von den Lungen-6 (KL-6), its structural features, functional mechanisms, and the current research status in various respiratory system diseases. Discovered in 1985, KL-6 was initially considered a tumor marker, but its elevated levels in interstitial lung disease (ILD) led to its recognition as a relevant serum marker for ILD. KL-6 is primarily produced by type 2 alveolar epithelial cell regeneration. Over the past 30 years since the discovery of KL-6, the number of related research papers has steadily increased annually. Following the coronavirus disease 2019 (COVID-19) pandemic, there has been a sudden surge in relevant literature. Despite KL-6's potential as a biomarker, its value in the diagnosis, treatment, and prognosis varies across different respiratory diseases, including ILD, idiopathic pulmonary fibrosis (IPF), COVID-19, and lung cancer. Therefore, as an important serum biomarker in respiratory system diseases, the value of KL-6 still requires further investigation.

1 January 2025 in The American Journal of Chinese Medicine
Verified
Journal Article
Closed access
YZYuzhe Zhang
Yuzhe Zhang
ZGZhengtao Gao
Zhengtao Gao
YLYanke Li
Yanke Li
LZLulu Zhang
Lulu Zhang
LYLirong Yan
Lirong Yan
YZYe Zhang
Ye Zhang